ECTS eCampus

This content is exclusively accessible to registered users.
To register click here
Abstract
Discussion Forum (0)
P086 - Psychosocial impact of COVID-19 pandemic on cancer patients with bone metastases (PsyCO-B): a multicentre prospective observational study

Topic: Cancer and bone

D'oronzo, Stella(1)*;Salonne, Francesco(1);Scardino, Natasha(1);Stucci, Stefania(2);Paparella, Giulia(3);Taurisano, Paolo(3);Abbatantuono, Chiara(3);De Caro, Maria Fara(3);Porta, Camillo(1);

(1)University of Bari Aldo Moro, Department of Biomedical Sciences and Human Oncology, Bari, Italy;(2)University Hospital Policlinico, Medical Oncology Unit, Bari, Italy;(3)University of Bari Aldo Moro, Department of Basic Medical Science- Neuroscience and Sense Organs, Bari, Italy;

Abstract Text

Background-COVID-19 pandemic has affected our daily habits and quality of life (QoL). Cancer patients with bone metastases (BM) are among the most concerned individuals, due not only to their clinical condition as a primary cause of morbidity, but also to social distancing which compromises their psychological and relational well-being.
 
Purpose-To determine the psychosocial impact of COVID-19 pandemic on patients with BM.

Methods-Cancer patients with radiological and/or histological diagnosis of BM were enrolled following written informed consent. Six questionnaires were administered: Hospital Anxiety-Depression Scale; WHO QoL-BREF; Attitude Toward Seeking Professional Psychological Help; Brief Illness Perception Questionnaire; Brief COPE; Impact Event Scale-Revised. Clinical, pathological and socio-demographics were collected and analyzed by descriptive statistics. After selection of the co-variates by univariate analysis, regression models were developed for multivariate analysis. Statistical analyses were performed using SPSS software, and p-values≤0.05 were considered significant.

Results-The study was approved by Local Ethics Committee. Between October and December 2021, 23 patients were enrolled, whose median age was 62 (range: 34-83). Among primary tumors, the most common were breast (38%), renal (28%) and lung cancer (9%). In most cases (66.6%) BM had been diagnosed after the pandemic outbreak. A statistically significant association emerged between younger age and depression onset (p<0.05). Females had to cope with more “intrusive thoughts”, and used religious coping strategies more frequently than males (p<0.05 in both instances). A significant correlation emerged between the burden of skeletal disease and QoL impairment (p<0.05). Finally, patients diagnosed with BM after the pandemic outbreak expressed a stronger need for psychological help (p=0.01).

Conclusion-These preliminary results show that receiving a diagnosis of BM during the pandemic negatively affected patients' QoL and increased their need for psychological support. Patient enrollment is still ongoing and will provide more accurate data to define an “identikit” of patient at high-risk of psychosocial distress.



P086 - Psychosocial impact of COVID-19 pandemic on cancer patients with bone metastases (PsyCO-B): a multicentre prospective observational study

Topic: Cancer and bone

D'oronzo, Stella(1)*;Salonne, Francesco(1);Scardino, Natasha(1);Stucci, Stefania(2);Paparella, Giulia(3);Taurisano, Paolo(3);Abbatantuono, Chiara(3);De Caro, Maria Fara(3);Porta, Camillo(1);

(1)University of Bari Aldo Moro, Department of Biomedical Sciences and Human Oncology, Bari, Italy;(2)University Hospital Policlinico, Medical Oncology Unit, Bari, Italy;(3)University of Bari Aldo Moro, Department of Basic Medical Science- Neuroscience and Sense Organs, Bari, Italy;

Abstract Text

Background-COVID-19 pandemic has affected our daily habits and quality of life (QoL). Cancer patients with bone metastases (BM) are among the most concerned individuals, due not only to their clinical condition as a primary cause of morbidity, but also to social distancing which compromises their psychological and relational well-being.
 
Purpose-To determine the psychosocial impact of COVID-19 pandemic on patients with BM.

Methods-Cancer patients with radiological and/or histological diagnosis of BM were enrolled following written informed consent. Six questionnaires were administered: Hospital Anxiety-Depression Scale; WHO QoL-BREF; Attitude Toward Seeking Professional Psychological Help; Brief Illness Perception Questionnaire; Brief COPE; Impact Event Scale-Revised. Clinical, pathological and socio-demographics were collected and analyzed by descriptive statistics. After selection of the co-variates by univariate analysis, regression models were developed for multivariate analysis. Statistical analyses were performed using SPSS software, and p-values≤0.05 were considered significant.

Results-The study was approved by Local Ethics Committee. Between October and December 2021, 23 patients were enrolled, whose median age was 62 (range: 34-83). Among primary tumors, the most common were breast (38%), renal (28%) and lung cancer (9%). In most cases (66.6%) BM had been diagnosed after the pandemic outbreak. A statistically significant association emerged between younger age and depression onset (p<0.05). Females had to cope with more “intrusive thoughts”, and used religious coping strategies more frequently than males (p<0.05 in both instances). A significant correlation emerged between the burden of skeletal disease and QoL impairment (p<0.05). Finally, patients diagnosed with BM after the pandemic outbreak expressed a stronger need for psychological help (p=0.01).

Conclusion-These preliminary results show that receiving a diagnosis of BM during the pandemic negatively affected patients' QoL and increased their need for psychological support. Patient enrollment is still ongoing and will provide more accurate data to define an “identikit” of patient at high-risk of psychosocial distress.



Psychosocial impact of COVID-19 pandemic on cancer patients with bone metastases (PsyCO-B): a multicentre prospective observational study
Stella D'oronzo
Stella D'oronzo
Affiliations:
University of Bari Aldo Moro, Bari, Italy
ECTS eCampus. D'oronzo S. 05/06/2022; 352219; P086
user
Stella D'oronzo
Affiliations:
University of Bari Aldo Moro, Bari, Italy
Abstract
Discussion Forum (0)
P086 - Psychosocial impact of COVID-19 pandemic on cancer patients with bone metastases (PsyCO-B): a multicentre prospective observational study

Topic: Cancer and bone

D'oronzo, Stella(1)*;Salonne, Francesco(1);Scardino, Natasha(1);Stucci, Stefania(2);Paparella, Giulia(3);Taurisano, Paolo(3);Abbatantuono, Chiara(3);De Caro, Maria Fara(3);Porta, Camillo(1);

(1)University of Bari Aldo Moro, Department of Biomedical Sciences and Human Oncology, Bari, Italy;(2)University Hospital Policlinico, Medical Oncology Unit, Bari, Italy;(3)University of Bari Aldo Moro, Department of Basic Medical Science- Neuroscience and Sense Organs, Bari, Italy;

Abstract Text

Background-COVID-19 pandemic has affected our daily habits and quality of life (QoL). Cancer patients with bone metastases (BM) are among the most concerned individuals, due not only to their clinical condition as a primary cause of morbidity, but also to social distancing which compromises their psychological and relational well-being.
 
Purpose-To determine the psychosocial impact of COVID-19 pandemic on patients with BM.

Methods-Cancer patients with radiological and/or histological diagnosis of BM were enrolled following written informed consent. Six questionnaires were administered: Hospital Anxiety-Depression Scale; WHO QoL-BREF; Attitude Toward Seeking Professional Psychological Help; Brief Illness Perception Questionnaire; Brief COPE; Impact Event Scale-Revised. Clinical, pathological and socio-demographics were collected and analyzed by descriptive statistics. After selection of the co-variates by univariate analysis, regression models were developed for multivariate analysis. Statistical analyses were performed using SPSS software, and p-values≤0.05 were considered significant.

Results-The study was approved by Local Ethics Committee. Between October and December 2021, 23 patients were enrolled, whose median age was 62 (range: 34-83). Among primary tumors, the most common were breast (38%), renal (28%) and lung cancer (9%). In most cases (66.6%) BM had been diagnosed after the pandemic outbreak. A statistically significant association emerged between younger age and depression onset (p<0.05). Females had to cope with more “intrusive thoughts”, and used religious coping strategies more frequently than males (p<0.05 in both instances). A significant correlation emerged between the burden of skeletal disease and QoL impairment (p<0.05). Finally, patients diagnosed with BM after the pandemic outbreak expressed a stronger need for psychological help (p=0.01).

Conclusion-These preliminary results show that receiving a diagnosis of BM during the pandemic negatively affected patients' QoL and increased their need for psychological support. Patient enrollment is still ongoing and will provide more accurate data to define an “identikit” of patient at high-risk of psychosocial distress.



P086 - Psychosocial impact of COVID-19 pandemic on cancer patients with bone metastases (PsyCO-B): a multicentre prospective observational study

Topic: Cancer and bone

D'oronzo, Stella(1)*;Salonne, Francesco(1);Scardino, Natasha(1);Stucci, Stefania(2);Paparella, Giulia(3);Taurisano, Paolo(3);Abbatantuono, Chiara(3);De Caro, Maria Fara(3);Porta, Camillo(1);

(1)University of Bari Aldo Moro, Department of Biomedical Sciences and Human Oncology, Bari, Italy;(2)University Hospital Policlinico, Medical Oncology Unit, Bari, Italy;(3)University of Bari Aldo Moro, Department of Basic Medical Science- Neuroscience and Sense Organs, Bari, Italy;

Abstract Text

Background-COVID-19 pandemic has affected our daily habits and quality of life (QoL). Cancer patients with bone metastases (BM) are among the most concerned individuals, due not only to their clinical condition as a primary cause of morbidity, but also to social distancing which compromises their psychological and relational well-being.
 
Purpose-To determine the psychosocial impact of COVID-19 pandemic on patients with BM.

Methods-Cancer patients with radiological and/or histological diagnosis of BM were enrolled following written informed consent. Six questionnaires were administered: Hospital Anxiety-Depression Scale; WHO QoL-BREF; Attitude Toward Seeking Professional Psychological Help; Brief Illness Perception Questionnaire; Brief COPE; Impact Event Scale-Revised. Clinical, pathological and socio-demographics were collected and analyzed by descriptive statistics. After selection of the co-variates by univariate analysis, regression models were developed for multivariate analysis. Statistical analyses were performed using SPSS software, and p-values≤0.05 were considered significant.

Results-The study was approved by Local Ethics Committee. Between October and December 2021, 23 patients were enrolled, whose median age was 62 (range: 34-83). Among primary tumors, the most common were breast (38%), renal (28%) and lung cancer (9%). In most cases (66.6%) BM had been diagnosed after the pandemic outbreak. A statistically significant association emerged between younger age and depression onset (p<0.05). Females had to cope with more “intrusive thoughts”, and used religious coping strategies more frequently than males (p<0.05 in both instances). A significant correlation emerged between the burden of skeletal disease and QoL impairment (p<0.05). Finally, patients diagnosed with BM after the pandemic outbreak expressed a stronger need for psychological help (p=0.01).

Conclusion-These preliminary results show that receiving a diagnosis of BM during the pandemic negatively affected patients' QoL and increased their need for psychological support. Patient enrollment is still ongoing and will provide more accurate data to define an “identikit” of patient at high-risk of psychosocial distress.



By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies